MPG.eBooks - Search Results

1

CADTH Canadian Drug Expert Committee recommendation: Insulin degludec (Tresiba -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

2

Second- and third-line pharmacotherapy for type 2 diabetes : update of CADTH 2010 reviews :project protocol

Published 2012

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

3

Third-line pharmacotherapy for type 2 diabetes : update

Published 2013

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

4

Pharmacoeconomic review report: Dapagliflozin (Forxiga)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

5

Pharmacoeconomic review report: Dapagliflozin (Forxiga)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

6

Pharmacoeconomic review report: Dexamethasone (Ozurdex) (Allergan Inc.)

Published 2018

CADTH

Subjects: “...Diabetes Complications / drug therapy...”

Read Now

7

Pharmacoeconomic review report: Glucagon nasal powder (Baqsimi) (Eli Lilly Canada Inc.) : indication: for the treatment of severe hypoglycemic reactions which may occur in the mana...

Published 2020

CADTH

Subjects: “...Diabetes Complications / drug therapy...”

Read Now

8

Islet transplantation for the treatment of type 1 diabetes

Published 2013

IHE, Institute of Health Economics

Subjects: “...Diabetes Mellitus, Type 1 / surgery...”

Read Now

9

Debridement procedures for managing diabetic foot ulcers : a review of clinical effectiveness, cost-effectiveness, and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetic Foot / economics...”

Read Now

10

Pharmacoeconomic review report: Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

11

Pharmacoeconomic review report: Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

12

Pharmacoeconomic review report: Empagliflozin and Metformin fixed-dose combination (Synjardy)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

13

CADTH Canadian Drug Expert Committee recommendation: Insulin glargine and lixisenatide (Soliqua -- Sanofi-Aventis Canada Inc.) : indication : adjunct to diet and exercise to improv...

Published 2019

CADTH

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

14

CADTH Canadian Drug Expert Committee recommendation: Glucagon nasal powder (Baqsimi -- Eli Lilly Canada Inc) : indication: for the treatment of severe hypoglycemia (SH) reactions w...

Published 2020

CADTH

Subjects: “...Diabetes Complications / drug therapy...”

Read Now

15

CADTH Canadian Drug Expert Committee recommendation: Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

16

Pharmacoeconomic review report: Empagliflozin (Jardiance)

Published 2015

CADTH

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

17

Pharmacoeconomic review report: Empagliflozin (Jardiance)

Published 2015

CADTH

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

18

Pharmacoeconomic review report: Insulin glargine + lixisenatide (Soliqua) (Sanofi-Aventis) : indication : adjunct to diet and exercise to improve glycemic control in adults with ty...

Published 2019

CADTH

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

19

Pharmacoeconomic review report: Insulin glargine + lixisenatide (Soliqua) (Sanofi-Aventis) : indication : adjunct to diet and exercise to improve glycemic control in adults with ty...

Published 2019

CADTH

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

20

CADTH Canadian Drug Expert Committee recommendation: Semaglutide (Ozempic -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, type 2 to improve glycemic control

Published 2019

CADTH

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Narrow Search